DSM-Firmenich AG (DSMFF)
DSM-Firmenich AG (DSMFF) Stock Price, Analysis & Data
| Geld | 103.11 |
| Marktkapitalisierung | 26.62 Mrd |
| Umsatz (TTM) | 9.05 Mrd |
| Nettogewinn (TTM) | 324 Mio |
| Beta | 0.56 |
| EPS (ttm) | 1.61 |
| KGV (TTM) | 67.08 |
| Forward-KGV | n/a |
| KBV (TTM) | 1.32 |
| KUV (TTM) | 2.94 |
| Earnings Date | Feb 18, 2027 |
| Brief | 104.43 |
| Volumen | 800 |
| Ø Vol. (20D) | 1,004 |
| Eröffnung | 108.00 |
| Vortagesschluss | 108.00 |
| Tagesspanne | 108.00 - 108.00 |
| 52-Wk Range | 67.00 - 108.00 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | $2.91 (2.7%) |
| Ex-Dividenden-Datum | 11. Mai 2026 |
Über DSMFF
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food ...
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von DSM-Firmenich 9.03 Mrd, ein Rückgang von -0.22% im Vergleich zum Vorjahr (9.05 Mrd). Der Gewinn lag bei -1.08 Mrd, ein Rückgang von -532.4 %.
FinanzberichteAnalysten erwarten einen Umsatz von ... Upgrade
vor 3 Monaten · Simply Wall St.
DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation UpsideDSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying Europe...
vor 5 Monaten · Simply Wall St.
Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Recent Share Price SwingsWhy DSM-Firmenich Shares Are Back On Investors’ Radar DSM-Firmenich (ENXTAM:DSFIR) has come into focus after recent share performance, with the stock showing a 0.1% move over the past week but a weake...